Latest Breaking News On - Phathom pharmaceuticals inc - Page 1 : comparemela.com

Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […]

United statesNew zealand generalNew zealandTerrie curranStifel nicolausMolly hendersonCatalys pacificNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticals stock performanceQuarter for phathom pharmaceuticalsPhathom pharmaceuticals incPrincipal financial group incInsider activity at phathom pharmaceuticalsBarclays plcSecurities exchange commissionWellington management group